PH CI-22 · 2026/27
Childhood Immunisations
Vaccination coverage at 12 months, 24 months and 5 years
Last update
1 October 2026
Data source
EMIS CSV
Refresh
Weekly · live
Next refresh
Auto · weekly
KPIs on target
0/10
10 below · 4 monitoring
Performance
80.8%
10 payment KPIs
Highest performing
CI-02-01
89% · target 90–95% · -6%
894 / 1,005
Lowest performing
CI-03-05
70.5% · target 87–95% · -24.5%
687 / 974
Most improved
—
Needs 2+ uploads
Below target (10)No data (4)Mon= Monitoring only — no payment threshold
| Indicator⇅ | Target⇅ | Target activity⇅ | Performance %⇅ | Activity⇅ | Population⇅ | Shortfall⇅ | Status | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 month cohort | ||||||||||||
| CI-01-01DTaP/IPV/Hib/HepB▸ | 90–95% | 954 | 85% | 853 | 1,004 | 101 | Below | |||||
| CI-01-02Men B (1st and 2nd)▸ | 90–95% | 954 | 87.2% | 875 | 1,004 | 79 | Below | |||||
| CI-01-03PCV▸ | 90–95% | 954 | 85.9% | 862 | 1,004 | 92 | Below | |||||
| CI-01-04Rotavirus▸ | 90–95% | 954 | 82.5% | 828 | 1,004 | 126 | Below | |||||
| 24 month cohort | ||||||||||||
| CI-02-01DTaP/IPV/Hib/HepB▸ | 90–95% | 955 | 89% | 894 | 1,005 | 61 | Below | |||||
| CI-02-02MMR▸ | 90–95% | 955 | 78.9% | 793 | 1,005 | 162 | Below | |||||
| CI-02-03HiB/Men CMon▸ | Monitoring | — | 7.1% | 71 | 1,005 | — | Monitoring | |||||
| CI-02-04PCV (Booster)▸ | 90–95% | 955 | 78.9% | 793 | 1,005 | 162 | Below | |||||
| CI-02-05Men B (Booster)▸ | 90–95% | 955 | 78.9% | 793 | 1,005 | 162 | Below | |||||
| 5 year cohort | ||||||||||||
| CI-03-01DTaP/IPV/Hib/HepBMon▸ | Monitoring | — | 89.1% | 868 | 974 | — | Monitoring | |||||
| CI-03-02MMR (Primary)Mon▸ | Monitoring | — | 87.4% | 851 | 974 | — | Monitoring | |||||
| CI-03-03DTaP/IPV (Booster)▸ | 87–95% | 926 | 71.5% | 696 | 974 | 230 | Below | |||||
| CI-03-04HiB/Men CMon▸ | Monitoring | — | 85.3% | 831 | 974 | — | Monitoring | |||||
| CI-03-05MMR (Booster)▸ | 87–95% | 926 | 70.5% | 687 | 974 | 239 | Below | |||||
Data as of 1 October 2026 · EMIS CSV · Refreshed weekly